Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Safety and Efficacy of Once Weekly Steroid in Patients With LGMD and Becker Muscular Dystrophy

NCT04054375 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04054375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04054375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Safety and Efficacy of Once Weekly Steroid in Patients With LGMD and Becker Muscular Dystrophy
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2019
Completion date
March 1, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, limb-girdle muscular dystrophy